Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H13N3O4 |
| Molecular Weight | 263.2493 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=[N+]([O-])C2=CC=CC=C2[N+]([O-])=C1C(=O)NCCO
InChI
InChIKey=TURHTASYUMWZCC-UHFFFAOYSA-N
InChI=1S/C12H13N3O4/c1-8-11(12(17)13-6-7-16)15(19)10-5-3-2-4-9(10)14(8)18/h2-5,16H,6-7H2,1H3,(H,13,17)
| Molecular Formula | C12H13N3O4 |
| Molecular Weight | 263.2493 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Olaquindox, a potent antibacterial agent, is used as an effective feed additive in the livestock industry. Olaquindox could potentially expose a human to the risk of biological hazards due to its genotoxicity and cytotoxicity. However, the potential mechanism of toxicity is still unknown. Recently was provided experiments to explore the molecular mechanism of p21 on olaquindox-induced mitochondrial apoptosis. It was shown, that olaquindox promoted the production of ROS, suppressed the protein expression p21 in a p53-independent way and phosphorylated p21. This experiment provided new insights into the molecular mechanism of olaquindox and shed light on the role of p21.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. | 2013-09 |
|
| Olaquindox induces apoptosis through the mitochondrial pathway in HepG2 cells. | 2011-07-29 |
|
| ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro. | 2010-05-14 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16024154
Subchronic oral toxicity study in rats: olaquindox (150 mg/kg), approximately equivalent to 15 mg/kg b.w./day, for 13 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29179463
It was deciphered the detrimental effects of olaquindox on male fertility by mechanistically unraveling how olaquindox intervenes blood-testis barrier in mouse. Olaquindox (400 μg/ml) exposure significantly compromised tight junction permeability function, decreased or dislocated the junction proteins (e.g., ZO-1, occludin and N-cadherin) and attenuated mTORC2 signaling pathway in primary Sertoli cells. Furthermore, olaquindox disrupted F-actin architecture through interfering with the expression of actin branching protein complex (CDC42-N-WASP-Arp3) and actin bunding protein palladin. Olaquindox also triggered severely DNA damage and apoptosis while inhibiting autophagic flux in Sertoli cell presumably due to the exacerbated generation of reactive oxygen species (ROS).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:13:33 GMT 2025
by
admin
on
Mon Mar 31 18:13:33 GMT 2025
|
| Record UNII |
G3LAW9U88T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QJ01MQ01
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3536
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
DTXSID3040726
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
m8186
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | Merck Index | ||
|
C90736
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL1649716
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
SUB09427MIG
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
100000083312
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
G3LAW9U88T
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
7025
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
23696-28-8
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
71905
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
245-832-7
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY | |||
|
C013168
Created by
admin on Mon Mar 31 18:13:33 GMT 2025 , Edited by admin on Mon Mar 31 18:13:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |